Melanoma News and Research

Latest Melanoma News and Research

U-M Health System study finds patient education video is excellent teaching tool but doctors are better at calming fears

In an age when people often learn health information from surfing the Web and watching television shows set in hospitals, researchers have found that showing patients an educational video about their condition teaches them the facts about their disease even better than when their doctor tells them about the condition.

26 Jul 2005

Gene that regulates normal embryonic development is found at high levels in virtually all forms of breast cancer

A gene that appears to help regulate normal embryonic development is found at high levels in virtually all forms of breast cancer, according to a new study led by Laszlo Radvanyi, Ph.D., associate professor of breast and melanoma medical oncology at The University of Texas M. D. Anderson Cancer Center.

25 Jul 2005

Provectus to begin clinical trials of new cancer treatment, PV-10

Provectus Pharmaceuticals announced today that it has obtained final clearance to begin the first Phase 1 clinical trial of PV-10, the Company's lead cancer treatment.

21 Jul 2005

Role of IL-24 in regulating the immune system

Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.

21 Jul 2005

Pineapple stems that show anti-tumour activity

Scientists at the Queensland Institute of Medical Research (QIMR) have discovered two molecules from pineapple stems that show anti-tumour activity in laboratory studies. One molecule called CCS blocks a protein called Ras, which is defective in approximately 30% of all cancers. The other molecule called CCZ, stimulates the body's own immune system to target and kill cancer cells.

19 Jul 2005

New method may accelerate the way cancer-causing genes are found

Researchers at the University of Minnesota Cancer Center and the National Cancer Institute (NCI) have discovered a new method that could accelerate the way cancer-causing genes are found and could lead to a more accurate identification of the genes, according to two studies in the July 14, 2005, issue of Nature.

13 Jul 2005

Curcumin has potent anticancer powers

Curcumin, a spice commonly used in curries and other south Asian cooking, blocks a key biological pathway needed for development of melanoma and other cancers, say researchers from the University of Texas M. D. Anderson Cancer Center.

12 Jul 2005

Researchers have pinpointed specific gene and protein over-production in metastatic melanoma

Gene amplification is a process that often happens in cancer cells when the normal DNA replication process is altered, causing many copies of the gene to be produced instead of a single copy of a region of a chromosome.

12 Jul 2005

Sunscreen plays a much more important role than just protecting against sunburn

The number of nevi, or moles, a person has is known to be a strong predictor of the future risk of developing skin cancer, particularly melanoma, the most deadly form of the disease. This number also is believed to be affected by the amount of sun exposure an individual receives.

12 Jul 2005

Good news for curry wallahs, ingredient helps fight cancer

In good news for curry wallahs, researchers are saying that a compound that makes curry yellow could help fight skin cancer.

11 Jul 2005

Researchers have discovered how p16 gene works

University of Minnesota researchers have discovered how a gene that suppresses the development of melanoma and other human cancers works. The study points the way to treatments based on the function of the gene.

11 Jul 2005

Zebrafish provides cancer researchers powerful new insights into the development of malignant melanoma

The embryo of a tiny, silvery tropical fish found in many home aquariums is providing cancer researchers at Northwestern University Feinberg School of Medicine with powerful new insights into the development of malignant melanoma, the deadliest form of skin cancer.

20 Jun 2005

Detection levels of deadly form of melanoma remains the same

Despite campaigns promoting early detection and increased awareness of melanoma (skin cancer) the proportion of the most aggressive and deadly form of melanoma remains the same, according to an article in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.

20 Jun 2005

High exposure to the sun halves risk of prostate cancer

Cancer researchers in the U.S. say that high exposure to the sun halved the risk of prostate cancer in men participating in a U.S. trial.

16 Jun 2005

Exposure to sunlight may decrease the risk of prostate cancer

In the largest such study to date, a research team from three cancer centers measured sunlight exposure in men and found that increased exposure to sunlight may decrease the risk of prostate cancer.

15 Jun 2005

Research urges a new approach to cancer detection

A few years ago, Medhat Osman, M.D., Ph.D., had a patient who was scanned due to a suspicion of lung cancer using positron emission tomography (PET) and computer tomography (CT) technology. The scan came back negative, but the patient then complained of a problem with his leg.

14 Jun 2005

Novel and more effective way of testing which gene mutations cause cancer

Often cancer research goes like this: study cancerous cells in a lab dish, find mutations that appear in many of the samples, develop drugs to target proteins made by the mutated genes, and voila, new chemotherapy drugs are born. Or at least that's the hope.

12 Jun 2005

Bio-engineered skin provides clues to melanoma development

When it comes to the deadly skin cancer melanoma, studying functional tissue rather than cell lines may better provide insight into the disease's development, according to new research from a Howard Hughes Medical Institute predoctoral fellow at Stanford University School of Medicine.

12 Jun 2005

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.

9 Jun 2005

New survey shows Americans falling short on sun protection

Over the past year, the number of Americans using sunscreen, a primary protector against skin cancer, has declined. At the same time, more Americans, including children, are being diagnosed with skin cancer than ever before.

6 Jun 2005